FeesSafety
Pluang+

Federal Signal posts 18% sales growth and raises 2026 EPS outlook amid strong orders and cash flow

Company Fundamentals
29 Oct 2026, 15:00 WIB
PRNewsWire
View Source
Bullish
Federal Signal posts 18% sales growth and raises 2026 EPS outlook amid strong orders and cash flow

Federal Signal Corporation reported an 18% increase in net sales to $656 million for Q3 2026, driven by strong demand and acquisitions. Operating income rose 19% to $111.4 million, with adjusted EPS up 18% to $1.34. Orders surged 33% to $620 million, supporting a raised full-year adjusted EPS forecast of $5.20 to $5.32. The company also generated $91 million in operating cash flow, enhancing financial flexibility for growth and shareholder returns.

Federal Signal's third quarter results show strong growth in sales, income, and orders. For readers following the Industrials sector, here is Pluang's market snapshot as of Oct 29, 2026 18:51 WIB: 69 of 135 US Industrials stocks rose today. Notable movers include VRT at USD 234.66 (-3.41%), GFL at USD 45.05 (+3.35%), and RKLB at USD 56.65 (-3.33%).

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
1 hour ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
1 hour ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
2 hours ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
2 hours ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App